Kyocera Corp (KYR)

But, just about 10 years of pain ombow and then we should be outta this brimstone (sulphur) and other issues
43:30 is a good summary as any, gl
https://www.youtube.com/watch?v=YlVPRutom6k

The Future

Over the next phase Bionano will move from selling a powerful lab tool to building the backbone of precision medicine by doing three practical things:

FIRST, make Saphyr the standard safety and diagnostic test that doctors and researchers use to spot big, har

What would be really good is if we get positive EA news from the govt AND Trumper revaluing gold. I think he'll revalue gold because of his ego. Just saw the proposed new US passport book pages - and Trump put a drawing of himself in the new passport design. C'mon, too much ego.

Smart move. Dumping Doug knew to sell this heap too.

Congrats on finishing the painting way to go!!!!! I know you’re happy!!!!

Either way, it's going up!!!!!

Jesspro, Otsuka already sells the drug in many countries,
if any company understands the potential it should be them.
Why they have not made a BO offer yet is beyond me. As time
goes by the patent clock continues to run and the potential value
of AUPH goes up as other d

Why do you need clearance to publish your own data. Companies do it all the time. The application was submitted 3 years ago. This app is already finished As in cooked.

Thanks, Wade, they have been all discussed on this board or picked at stock picking competitions. I feel uneasy to specifically list them all in one message and disclose publicly, because the top one has grown into over 50% of my total portfolio even after I sold 10%. It has been a 40 bagger, and my

understanding value
value must go lower for market prices to be lower
shadow
https://www.youtube.com/watch?v=xu-X7sYY6Hk

Really.

Our Fortress Report is built for professional investors who understand the mechanics of the market, which is a world apart from the FOMO-driven trading mentality.

Is that why you're here - on a penny stock forum? That's really what iHub was made for. Penny st

Deklan’s team won one and lost one yesterday. They play today at 10am. I went to my daughter’s house and FINISHED UP THE PAINTING LAST NIGHT. It’s finally all done inside the house. I still have to paint the outside trim and stuff but I can do that whenever. I was hurrying the inside so they could g

This has been petitioned by custodian P. Kumalarasan on 4-21-26. This Is a SEC reporting shell. Seems he has had to refile this again? Nice SS here. watching this one

Thompson’s GMO silkworm silk is just as slow, resource-intensive, and labor-intensive to produce as mundane silk.  Indeed, it likely has higher production costs given the difficulties in maintaining quality over generations.
It will never be as cheap as cotton or wool.
It is also not s

Why you think that bruv?

https://grok.com/share/bGVnYWN5LWNvcHk_4ce243d3-b82d-4888-bec5-420c19217881

I'm not smart enough to know how this whole Bitcoin thing works out if Strategy goes bust, but it certainly looks more likely to happen barring some sort of intervention to save them. Like I've said before, maybe Saylor makes some sort of deal with Trump to buy his (Strategy's) Bitcoin on the cheap

Follow us on Substack and LinkedIn for more deep dives and market updates.

Materiality is not “black and white thinking.”

It is a disclosure threshold.

There can be judgment involved in deciding whether something is material, but the question is still fair.

If PSM is not material to the regulatory case, then stop treating it as

$BEI | Beiersdorf: The ultimate defensive fortress for a conservative portfolio

We finalized our deep dive analysis on Beiersdorf AG ($BEI / $BDRFY) just a few days ago, and the current market setup only reinforces our thesis. We are absolutely convinced that this stock is a perfect f

Doc, “authorities” being plural does not make the warning FDA only. It means the warning is broad enough to cover more than one regulatory authority. That can include FDA later, but it also includes MHRA while the UK MAA is pending.

The filing did not say FDA may not “approve” an SAP.

The Company expects to receive FDA feedback or decision within the standard 30-day review period.

Tazzie 97-54-77-16 Moose5-97-9-71 Chance 97-5-9-71 New 97-5-71-17
GLTA